Skip to main content

Treatment of Hyperbilirubinemia in Newborns

  • Reference work entry
  • First Online:
Neonatology

Abstract

The main aim of treating hyperbilirubinemia is to prevent kernicterus and/or neurodevelopmental impairment. Recommendations for treatment are based primarily on the total serum bilirubin (TSB) levels but also as a function of gestational age, birth weight, bilirubin/albumin ratios, and risk factors that increase the risk of bilirubin neurotoxicity. Setting thresholds for intervention in the premature neonate is more challenging than in term babies. Phototherapy is effective in lowering the circulating bilirubin or preventing it from rising further; its primary purpose is to prevent the need for an exchange transfusion. Phototherapy uses visible light energy to change the shape and structure of bilirubin, converting it to molecules that can be excreted even when normal conjugation is deficient. Exchange transfusion remains an important if infrequently required intervention. It is recommended in any infant who is jaundiced and manifests signs of intermediate to advanced stages of acute bilirubin encephalopathy even if the TSB is falling. Pharmacologic agents used in the management of hyperbilirubinemia can accelerate the normal metabolic pathways for bilirubin clearance, inhibit the enterohepatic circulation of bilirubin, and interfere with bilirubin formation by blocking the degradation of heme or inhibiting hemolysis. Currently, the only drug in clinical use is intravenous immunoglobulin.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 479.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 799.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Ackerman BD, Dyer GY, Taylor PM (1971) Decline in serum bilirubin concentration coincident with clinical onset of kernicterus. Pediatrics 48:647–650

    CAS  PubMed  Google Scholar 

  • Ahlfors CE (1994) Criteria for exchange transfusion in jaundiced newborns. Pediatrics 93:488–494

    CAS  PubMed  Google Scholar 

  • American Academy of Pediatrics, Subcommittee on Hyperbilirubinemia (2004) Clinical practice guideline: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 114:297–316

    Article  Google Scholar 

  • American Association of Blood Banks Technical Manual Committee (2002) Perinatal issues in transfusion practice. In: Brecher M (ed) Technical manual. American Association of Blood Banks, Bethesda, pp 497–515

    Google Scholar 

  • Amin SB, Ahlfors CE, Orlando MS et al (2001) Bilirubin and serial auditory brainstem responses in premature infants. Pediatrics 107:664–670

    Article  CAS  PubMed  Google Scholar 

  • Arnold C, Tyson JE, Cuadrado ME et al (2015) Cycled phototherapy: a safer effective treatment for small premature infants. EPAS 1582.605

    Google Scholar 

  • Aycicek A, Erel O (2007) Total oxidant/antioxidant status in jaundiced newborns before and after phototherapy. J Pediatr (Rio J) 83:319–322

    Google Scholar 

  • Bender GJ, Cashore WJ, Oh W (2007) Ontogeny of bilirubin-binding capacity and the effect of clinical status in premature infants born at less than 1300 grams. Pediatrics 120:1067–1073

    Article  PubMed  Google Scholar 

  • Benders MJNL, van Bel F, van de Bor M (1999) Haemodynamic consequences of phototherapy in term infants. Eur J Pediatr 158:323–328

    Article  CAS  PubMed  Google Scholar 

  • Bratlid D, Nakstad B, Hansen TW (2011) National guidelines for treatment of jaundice in the newborn. Acta Paediatr 100:499–505

    Article  CAS  PubMed  Google Scholar 

  • Brown AK, Kim MH, Wu PYK et al (1985) Efficacy of phototherapy in prevention and management of neonatal hyperbilirubinemia. Pediatrics 75:393–400

    CAS  PubMed  Google Scholar 

  • Cashore WJ (1980) Free bilirubin concentrations and bilirubin-binding affinity in term and preterm infants. J Pediatr 96:521–527

    Article  CAS  PubMed  Google Scholar 

  • Cashore WJ, Oh W (1982) Unbound bilirubin and kernicterus in low birthweight infants. Pediatrics 69:481–485

    CAS  PubMed  Google Scholar 

  • Cashore WJ, Oh W, Brodersen R (1983) Reserve albumin and bilirubin toxicity index in infant serum. Acta Paediatr Scand 72:415–419

    Article  CAS  PubMed  Google Scholar 

  • Cnattingius S, Zack MM, Ekbom A et al (1995) Prenatal and neonatal risk factors for childhood lymphatic leukemia. J Natl Cancer Inst 87:908–914

    Article  CAS  PubMed  Google Scholar 

  • Cremer RJ, Perryman PW, Richards DH (1958) Influence of light on the hyperbilirubinemia of infants. Lancet 1:1094–1097

    Article  CAS  PubMed  Google Scholar 

  • Csoma Z, Hencz P, Orvos H et al (2007) Neonatal blue-light phototherapy could increase the risk of dysplastic nevus development. Pediatrics 119:1036–1037

    Article  PubMed  Google Scholar 

  • Dagoglu T, Ovali F, Samanci N et al (1995) High-dose intravenous immunoglobulin therapy for haemolytic disease. J Internat Med Res 23:264–271

    Article  CAS  Google Scholar 

  • Dahlquist G, Kallen B (2003) Indications that phototherapy is a risk factor for insulin-dependent diabetes. Diabetes Care 26:247–248

    Article  PubMed  Google Scholar 

  • Daood MJ, McDonagh AF, Watchko JF (2009) Calculated free bilirubin levels and neurotoxicity. J Perinatol 29:S14–S19

    Article  CAS  PubMed  Google Scholar 

  • Djokomuljanto S, Quah BS, Surini Y et al (2006) Efficacy of phototherapy for neonatal jaundice is increased by the use of low-cost white reflecting curtains. Arch Dis Child Fetal Neonatal Ed 91:F439–F442

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dollberg S, Atherton HD, Hoath SB (1995) Effect of different phototherapy lights on incubator characteristics and dynamics under three modes of servocontrol. Am J Perinatol 12:55–60

    Article  CAS  PubMed  Google Scholar 

  • Donneborg ML, Knudsen KB, Ebbesen F (2010) Effect of infants’ position on serum bilirubin level during conventional phototherapy. Acta Paediatr 99:1131–1134

    Article  CAS  PubMed  Google Scholar 

  • Ebbesen F, Brodersen R (1982) Risk of bilirubin acid precipitation in preterm infants with respiratory distress syndrome: Considerations of blood/brain bilirubin transfer equilibrium. Early Hum Dev 6:341–355

    Article  CAS  PubMed  Google Scholar 

  • Ebbesen F, Nyboe J (1983) Postnatal changes in the ability of plasma albumin to bind bilirubin. Acta Paediatr Scand 72:665–670

    Article  CAS  PubMed  Google Scholar 

  • Esbjorner E (1991) Albumin binding properties in relation to bilirubin and albumin concentrations during the first week of life. Acta Paediatr Scand 80:400–405

    Article  CAS  PubMed  Google Scholar 

  • Figueras-Aloy J, Rodriguez-Miguelez JM, Iriondo-Sanz M et al (2010) Intravenous immunoglobulin and necrotizing enterocolitis in newborns with hemolytic disease. Pediatrics 125:139–144

    Article  PubMed  Google Scholar 

  • Funato M, Tamai H, Shimada S, Nakamura H (1994) Vigintiphobia, unbound bilirubin, and auditory brainstem responses. Pediatrics 93:50–53

    CAS  PubMed  Google Scholar 

  • Gottstein R, Cooke R (2003) Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn. Arch Dis Child Fetal Neonatol Ed 88:F6–F10

    Article  CAS  Google Scholar 

  • Govaert P, Lequin M, Swarte R et al (2003) Changes in globus pallidus with (pre) term kernicterus. Pediatrics 112:1256–1263

    Article  PubMed  Google Scholar 

  • Haddock JH, Nadler HL (1970) Bilirubin toxicity in human cultivated fibroblasts and its modification by light treatment. Proc Soc Exp Biol Med 134:45–48

    Article  CAS  PubMed  Google Scholar 

  • Hammerman C, Vreman HJ, Kaplan M et al (1996a) Intravenous immune globulin in neonatal immune hemolytic disease: does it reduce hemolysis? Acat Paediatr 85:1351–1353

    Article  CAS  Google Scholar 

  • Hammerman C, Kaplan M, Vreman HJ et al (1996b) Intravenous immune globulin in neonatal ABO isoimmunization: Factors associated with clinical efficacy. Biol Neonate 170:69–74

    Article  Google Scholar 

  • Hansen TWR (1997) Acute management of extreme neonatal jaundice – the potential benefits of intensified phototherapy and interruption of enterohepatic bilirubin circulation. Acta Paediatr 86:843–846

    Article  CAS  PubMed  Google Scholar 

  • Hansen TWR, Nietsch L, Norman E et al (2009) Reversibility of acute intermediate phase bilirubin encephalopathy. Acta Paediatr 98:1689–1694

    Article  PubMed  Google Scholar 

  • Harris MC, Bernbaum JC, Polin JR et al (2001) Developmental follow-up of breastfed term and near-term infants with marked hyperbilirubinemia. Pediatrics 107:1075–1080

    Article  CAS  PubMed  Google Scholar 

  • Hegyi T, Graff M, Zapanta V et al (1986) Transcutaneous bilirubinometry. III. Dermal bilirubin kinetics under green and blue light phototherapy. Am J Dis Child 140:994–997

    Article  CAS  PubMed  Google Scholar 

  • Hintz SR, Stevenson DK, Wong R et al (2011) Is phototherapy exposure associated with better or worse outcomes in 501- to 1000-g-birth-weight infants? Acta Paediatr 100:960–965

    Article  PubMed  PubMed Central  Google Scholar 

  • Hulzebos CV, Dijk PH, van Imhoff DE et al (2014) The bilirubin albumin ratio in the management of hyperbilirubinemia in preterm infants to improve neurodevelopmental outcome: a randomized controlled trial – the BARTrial. PLoS One 9, e99466

    Article  PubMed  PubMed Central  Google Scholar 

  • Ip S, Glicken S, Kulig J et al (2003) Management of neonatal hyperbilirubinemia. AHRQ Publication, Rockville

    Google Scholar 

  • Ip S, Chung M, Kulig J et al (2004) An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics 114:e130–e153

    Article  PubMed  Google Scholar 

  • Jackson JC (1997) Adverse events associated with exchange transfusion in healthy and ill newborns. Pediatrics 99, e7

    Article  CAS  PubMed  Google Scholar 

  • Jährig K, Jährig D, Meisel P (1982) Dependence of the efficiency of phototherapy on plasma bilirubin concentration. Acta Paediatr Scand 71:293–299

    Article  PubMed  Google Scholar 

  • Kaplan M, Kaplan E, Hammerman C et al (2006) Post-phototherapy neonatal bilirubin rebound: a potential cause of significant hyperbilirubinaemia. Arch Dis Child 91:31–34

    Article  CAS  PubMed  Google Scholar 

  • Kappas A (2004) A method for interdicting the development of severe jaundice in newborns by inhibiting the production of bilirubin. Pediatrics 113:119–123

    Article  PubMed  Google Scholar 

  • Kappas A, Drummond GS, Munson DP, Marshall JR (2001) Sn-mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah’s Witness newborns as an alternative to exchange transfusion. Pediatrics 108:1374–1377

    Article  CAS  PubMed  Google Scholar 

  • Kara S, Ulu-ozkan H, Yilmaz Y et al (2013) Necrotizing enterocolitis in a newborn following intravenous immunoglobulin treatment for haemolytic disease. J Coll Physicians Surg Pak 23:598–600

    PubMed  Google Scholar 

  • Keenan WJ, Novak KK, Sutherland JM et al (1985) Morbidity and mortality associated with exchange transfusion. Pediatrics (Suppl) 75:417–421

    CAS  Google Scholar 

  • Kopelman AE, Brown RS, Odell GB (1972) The “bronze” baby syndrome: A complication of phototherapy. J Pediatr 81:466–472

    Article  CAS  PubMed  Google Scholar 

  • Krishnan L, Pathare A (2011) Necrotizing enterocolitis in a term neonate following intravenous immunoglobin therapy. Indian J Pediatr 78:743–744

    Article  PubMed  Google Scholar 

  • Krishnan L, Pathare A (2012) Author’s Reply. Correspondence in regard to necrotizing enterocolitis in a term neonate following intravenous immunoglobulin therapy. Indian J Pediatr 79:1677

    Google Scholar 

  • Lai YC, Yew YW 2015 Neonatal blue light phototherapy and melanocytic nevus count in children: a systemic review and meta-analysis of observational studies. Ped Dermatology https://doi.org/10.1111/pde.12730. [Epub ahead of print]

    Article  PubMed  Google Scholar 

  • Lamola AA, Eisinger J, Blumberg WE et al (1979) Fluorometric study of the partition of bilirubin among blood components: basis for rapidmicorassays of bilirubin and bilirubin binding capacity in whole blood. Anal Biochem 100:25–42

    Article  CAS  PubMed  Google Scholar 

  • Lau SP, Fung KP (1984) Serum bilirubin kinetics in intermittent phototherapy of physiological jaundice. Arch Dis Child 59:892–894

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lightner DA, McDonagh AF (1984) Molecular mechanisms of phototherapy for neonatal jaundice. Acc Chem Res 17:417–424

    Article  CAS  Google Scholar 

  • Lipsitz PJ, Gartner LM, Bryla DA (1985) Neonatal and infant mortality in relationship to phototherapy. Pediatrics 75(Suppl):422–441

    CAS  PubMed  Google Scholar 

  • Louis D, More K, Oberoi S et al (2014) Intravenous immunoglobulin in isoimmune haemolytic disease of newborn: an updated systematic review and meta-analysis. Arch Dis Child Fetal Neonatal 99:F1–F7

    Article  Google Scholar 

  • Maayan-Metzger A, Yosipovitch G, Hadad E et al (2001) Transepidermal water loss and skin hydration in preterm infants during phototherapy. Am J Perinatol 18:393–396

    Article  CAS  PubMed  Google Scholar 

  • Maisels MJ (1996) Why use homeopathic doses of phototherapy? Pediatrics 98:283–287

    CAS  PubMed  Google Scholar 

  • Maisels MJ (2001) Phototherapy – traditional and nontraditional. J Perinatol 21:S93–S97

    Article  PubMed  Google Scholar 

  • Maisels MJ, Kring E (2002) Rebound in serum bilirubin level following intensive phototherapy. Arch Pediatr Adolesc Med 156:669–672

    Article  PubMed  Google Scholar 

  • Maisels MJ, Kring EA (2006a) Does intensive phototherapy produce hemolysis in newborns of 35 or more weeks gestation? J Perinatol 26:498–500

    Article  CAS  PubMed  Google Scholar 

  • Maisels MJ, Kring E (2006b) The contribution of hemolysis to early jaundice in normal newborns. Pediatrics 118:276–279

    Article  PubMed  Google Scholar 

  • Maisels MJ, McDonagh AF (2008) Phototherapy for neonatal jaundice. N Engl J Med 358:920–928

    Article  CAS  PubMed  Google Scholar 

  • Maisels MJ, Watchko JF (2003) Treatment of jaundice in low birthweight infants. Arch Dis Child Fetal Neonatol Ed 88:F459–F463

    Article  CAS  Google Scholar 

  • Maisels MJ, Kring EA, DeRidder J (2007) Randomized controlled trial of light-emitting diode phototherapy. J Perinatol 27:565–567

    Article  CAS  PubMed  Google Scholar 

  • Maisels MJ, Watchko JF, Bhutani VK, Stevenson DK (2012) An approach to the management of hyperbilirubinemiain the preterm infant less than 35 weeks of gestation. J Perinatol 32:660–664

    Article  CAS  PubMed  Google Scholar 

  • Mallon E, Wojnarowska F, Hope P, Elder G (1995) Neonatal bullous eruption as a result of transient porphyrinemia in a premature infant with hemolytic disease of the newborn. J Am Acad Dermatol 33:333–336

    Article  CAS  PubMed  Google Scholar 

  • Martinez JC, Maisels MJ, Otheguy L et al (1993) Hyperbilirubinemia in the breastfed newborn: a controlled trial of four interventions. Pediatrics 91:470–473

    CAS  PubMed  Google Scholar 

  • Maurer HM, Kirkpatrick BV, McWilliams NB et al (1985) Phototherapy for hyperbilirubinemia of hemolytic disease of the newborn. Pediatrics (Suppl) 75:407–412

    CAS  Google Scholar 

  • McDonagh AF (1990) Is bilirubin good for you? Clin Perinatol 17:359–369

    Article  CAS  PubMed  Google Scholar 

  • McDonagh AF, Maisels MJ (2006) Bilirubin unbound: deja vu all over again? Pediatrics 117:523–525

    Article  PubMed  Google Scholar 

  • Messner KH, Maisels MJ, Leure-DuPree AE (1978) Phototoxicity to the newborn primate retina. Invest Ophthalmol Vis Sci 17:178182

    Google Scholar 

  • Moll M, Goelz R, Naegele T, Wilke M, Poets CF (2011) Are recommended phototherapy thresholds safe enough for extremely low birth weight (ELBW) infants? A report on 2 ELBW infants with kernicterus despite only moderate hyperbilirubinemia. Neonatology 99:90–94

    Article  CAS  PubMed  Google Scholar 

  • Morris BH, Oh W, Tyson JE et al (2008) Aggressive vs. conservative phototherapy for infants with extremely low birth weight. New Engl J Med 359:1885–1896

    Article  CAS  PubMed  Google Scholar 

  • Mreihil K, McDonagh AF, Nakstad B et al (2010) Early isomerization of bilirubin in phototherapy of neonatal jaundice. Pediatr Res 67:656–659

    Article  CAS  PubMed  Google Scholar 

  • Mreihil K, Madsen P, Nakstad B et al (2015) Early formation of bilirubin isomers during phototherapy for neonatal jaundice: effects of single vs. double flourescent lamps vs. photodiodes. Pediatr Res 78:56–62

    Article  CAS  PubMed  Google Scholar 

  • Nakamura H, Yonetani M, Uetani Y et al (1992) Determination of serum unbound bilirubin for prediction of kernicterus in low birth weight infants. Acta Paediatr Jpn 54:642–647

    Article  Google Scholar 

  • National Institute for Health and Clinical Excellence (2010) Neonatal jaundice. www.nice.org.uk/CG98

  • Navarro M, Negre S, Matoses ML et al (2009) Necrotizing enterocolitis following the use of intravenous immunoglobulin for haemolytic disease of the newborn. Acta Paediatr 98:1214–1217

    Article  PubMed  Google Scholar 

  • Newman TB, Maisels MJ (1990) Does hyperbilirubinemia damage the brain of healthy full-term infants? Clin Perinatol 17:331–358

    Article  CAS  PubMed  Google Scholar 

  • Newman TB, Liljestrand P, Jeremy RJ et al (2006) Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more. N Engl J Med 354:1889–1900

    Article  CAS  PubMed  Google Scholar 

  • Newman TB, Kuzniewicz MW, Liljestrand P et al (2009) Numbers needed to treat with phototherapy according to American academy of pediatrics guidelines. Pediatrics 123:1352–1359

    Article  PubMed  Google Scholar 

  • Oh W, Tyson JE, Fanaroff AA et al (2003) Association between peak serum bilirubin and neurodevelopmental outcomes in extremely low birth weight infants. Pediatrics 112:773–779

    Article  PubMed  Google Scholar 

  • Oh W, Stevenson DK, Tyson JE et al (2010) Influence of clinical status on the association between plasma total and unbound bilirubin and death or adverse neurodevelopmental outcomes in extremely low birth weight infants. Acta Paediatr 99:673–678

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Paller AS, Eramo LR, Farrell EE et al (1997) Purpuric phototherapy-induced eruption in transfused neonates: relation to transient porphyrinemia. Pediatrics 100:360–364

    Article  CAS  PubMed  Google Scholar 

  • Patra K, Storfer-Isser A, Siner B (2004) Adverse events associated with neonatal exchange transfusion in the 1990s. J Pediatr 144:626–631

    Article  PubMed  Google Scholar 

  • Procianoy RS, Silveira RC, Fonseca LT et al (2010) The influence of phototherapy on serum cytokine concentrations in newborn infants. Am J Perinatol 27:375–379

    Article  PubMed  Google Scholar 

  • Rennie JM, Sehgal A, De A et al (2009) Range of UK practice regarding thresholds for phototherapy and exchange transfusion in neonatal hyperbilirubinaemia. Arch Dis Child Fetal Neonatol Ed 94:F323–F327

    Article  CAS  Google Scholar 

  • Robertson L, Harrild K (2010) Maternal and neonatal risk factors for childhood type 1 diabetes: a matched case–control study. BMC Public Health 10:281

    Article  PubMed  PubMed Central  Google Scholar 

  • Rogerson AG, Grossman ER, Gruber HS et al (1986) 14 years of experience with home phototherapy. Clin Pediatr 25:296–299

    Article  CAS  Google Scholar 

  • Roman E, Ansell P, Bull D (1997) Leukaemia and non-Hodgkin’s lymphoma in children and young adults: are prenatal and neonatal factors important determinants of disease? Brit J Cancer 76:406–415

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rubaltelli FF, Jori G, Reddi E (1983) Bronze baby syndrome: A new porphyrin-related disorder. Pediatr Res 17:327–330

    Article  CAS  PubMed  Google Scholar 

  • Rubaltelli FF, Guerrini P, Reddi E, Jori G (1989) Tin-protoporphyrin in the management of children with Crigler-Najjar disease. Pediatrics 84:728–731

    CAS  PubMed  Google Scholar 

  • Rübo J, Albrecht K, Lasch P et al (1992) High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease. J Pediatr 121:93–97

    Article  PubMed  Google Scholar 

  • Santos MC, Sa CA, Gomes SC, Camacho LA et al (2013) High-dose intravenous immunoglobulin therapy for hyperbilirubinemia due to Rh hemolytic disease: a randomized clinical trial. Transfusion 53:777–782

    Article  CAS  PubMed  Google Scholar 

  • Scheidt PC, Graubard BI, Nelson KB et al (1991) Intelligence at six years in relation to neonatal bilirubin level: follow-up of the National Institute of Child Health and Human Development Clinical Trial of Phototherapy. Pediatrics 87:797–805

    CAS  PubMed  Google Scholar 

  • Schulz S, Wong RJ, Vreman HJ et al (2012) Metalloporphyrins – an update. Front Pharmacol 3:68

    Article  PubMed  PubMed Central  Google Scholar 

  • Sedlak TW, Snyder SH (2004) Bilirubin benefits: cellular protection by a biliverdin reductase antioxidant cycle. Pediatrics 113:17761782

    Article  Google Scholar 

  • Seidman DS, Moise J, Ergaz Z et al (2003) A prospective randomized controlled study of phototherapy using blue and blue-green light-emitting devices, and conventional halogen-quartz phototherapy. J Perinatol 23:123–127

    Article  PubMed  Google Scholar 

  • Shinwell ES, Sciaky Y, Karplus M (2002) Effect of position changing on bilirubin levels during phototherapy. J Perinatol 22:226–229

    Article  CAS  PubMed  Google Scholar 

  • Silberberg DH, Johnson L, Schutta H et al (1970) Effects of photodegradation products of bilirubin on myelinating cerebellum cultures. J Pediatr 77:613–618

    Article  CAS  PubMed  Google Scholar 

  • Sims ME (2011) Legal briefs: Kernicterus still preventable. NeoReviews 12:e727–e730

    Article  Google Scholar 

  • Sisson TR, Whalen LE, Telel A (1958) A comparison of effects of whole blood and sedimented erythrocytes in exchange transfusion. Pediatrics 21:81–89

    CAS  PubMed  Google Scholar 

  • Slater L, Brewer MF (1984) Home versus hospital phototherapy for term infants with hyperbilirubinemia: a comparative study. Pediatrics 73:515–519

    CAS  PubMed  Google Scholar 

  • Slusher TM, Vreman HJ, Olusanya BO et al (2014) Safety and efficacy of filtered sunlight in treatment of jaundice in African neonates. Pediatrics 133:e1568–e1574

    Article  PubMed  PubMed Central  Google Scholar 

  • Slusher TM, Olusanya BO, Vreman HJ et al (2015) A randomized trial of phototherapy with filtered sunlight in African neonates. New Engl J Med 373:1115–1124

    Article  CAS  PubMed  Google Scholar 

  • Smits-Wintjens VEHJ, Walther FJ et al (2011) Intravenous immunoglobulin in neonates with rhesus hemolytic disease: a randomized controlled trial. Pediatrics 127:680–686

    Article  PubMed  Google Scholar 

  • Sproul A, Smith L (1964) Bilirubin equilibration during exchange transfusion in hemolytic disease of the newborn. J Pediatr 65:12–26

    Article  CAS  PubMed  Google Scholar 

  • Strauss KA, Robinson DL, Vreman HJ et al (2006) Management of hyperbilirubinemia and prevention of kernicterus in 20 patients with Crigler-Najjar disease. Eur J Pediatr 165:306–319

    Article  PubMed  Google Scholar 

  • Sugama S, Soeda A, Eto Y (2001) Magnetic resonance imaging in three children with kernicterus. Pediatr Neurol 25:328–331

    Article  CAS  PubMed  Google Scholar 

  • Tan KL (1982) The pattern of bilirubin response to phototherapy for neonatal hyperbilirubinemia. Pediatr Res 16:670–674

    Article  CAS  PubMed  Google Scholar 

  • Tatli MM, Minnet C, Kocyigit A et al (2008) Phototherapy increases DNA damage in lymphocytes of hyperbilirubinemic neonates. Mutat Res 654:93–95

    Article  CAS  PubMed  Google Scholar 

  • Tonz O, Vogt J, Filippini L et al (1975) Severe light dermatosis following phototherapy in a newborn infant with congenital erythropoietic uroporphyria. Helv Paediatr Acta 30:47–56

    CAS  PubMed  Google Scholar 

  • Tyson JE, Pedroza C, Langer J et al (2012) Does aggressive phototherapy increase mortality while decreasing profound impairment among the smallest and sickest newborns? J Perinatol 32:677–684

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Valaes T (1963) Bilirubin distribution and dynamics of bilirubin removal by exchange transfusion. Acta Paediatr 52(suppl 149):1–115

    Google Scholar 

  • Valaes T, Petmezaki S, Henschke C et al (1994) Control of jaundice in preterm newborns by an inhibitor of bilirubin production: studies with tin-mesoporphyrin. Pediatrics 93:1–11

    CAS  PubMed  Google Scholar 

  • Vandborg PK, Hansen BM, Greisen G et al (2012) Dose–response relationship of phototherapy for hyperbilirubinemia. Pediatrics 130:e352–e357

    Article  PubMed  Google Scholar 

  • Vogl TP, Hegyi T, Hiatt IM et al (1978) Intermittent phototherapy in the treatment of jaundice in the premature infant. J Pediatr 92:627–630

    Article  CAS  PubMed  Google Scholar 

  • Voto LS, Sexer H, Ferreiro G et al (1995) Neonatal adminstration of high-dose intravenous immunoglobulin and rhesus hemolytic disease. J Perinat Med 23:443–451

    Article  CAS  PubMed  Google Scholar 

  • Vreman HJ, Wong RJ, Stevenson DK (2004) Phototherapy: current methods and future directions. Semin Perinatol 28:326–333

    Article  PubMed  Google Scholar 

  • Watchko JF (2000) Exchange transfusion in the management of neonatal hyperbilirubinemia. In: Maisels MJ, Watchko JF (eds) Neonatal Jaundice. Harwood Academic Publishers, London, pp 169–176

    Google Scholar 

  • Watchko JF (2014) Recent advances in the management of neonatal jaundice. Res Rep Neonatol 4:183–193

    Google Scholar 

  • Watchko JF (2016) Bilirubin-induced neurotoxicity in the preterm neonate. Clin Perinatol 43:297–311

    Article  PubMed  Google Scholar 

  • Watchko JF, Maisels MJ (2014) The enigma of low bilirubin kernicterus in premature infants:why does it still occur, and is it preventable? Semin Perinatol 38:397–406

    Article  PubMed  Google Scholar 

  • Watchko JF, Tiribelli C (2013) Bilirubin-induced neurologic damage – mechanisms and management approaches. N Engl J Med 369:2021–2030

    Article  CAS  PubMed  Google Scholar 

  • Wennberg RP, Ahlfors CE, Bhutani V et al (2006) Toward understanding kernicterus: a challenge to improve the management of jaundiced newborns. Pediatrics 117:474–485

    Article  PubMed  Google Scholar 

  • Yamauchi Y, Casa N, Yamanouchi I (1989) Is it necessary to change the babies’ position during phototherapy? Early Hum Dev 20:221–227

    Article  CAS  PubMed  Google Scholar 

  • Yetman RJ, Parks DK, Huseby V et al (1998) Rebound bilirubin levels in infants receiving phototherapy. J Pediatr 133:705–707

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jon F. Watchko .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Watchko, J.F., Maisels, M.J. (2018). Treatment of Hyperbilirubinemia in Newborns. In: Buonocore, G., Bracci, R., Weindling, M. (eds) Neonatology. Springer, Cham. https://doi.org/10.1007/978-3-319-29489-6_223

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-29489-6_223

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-29487-2

  • Online ISBN: 978-3-319-29489-6

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics